| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| ipilimumab nivolumab fiche patient | 0.25 | 0.2 | 6568 | 59 | 34 |
| ipilimumab | 1.56 | 0.1 | 7056 | 94 | 10 |
| nivolumab | 1.8 | 0.3 | 942 | 25 | 9 |
| fiche | 0.03 | 1 | 2644 | 94 | 5 |
| patient | 1.68 | 0.3 | 234 | 81 | 7 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| ipilimumab nivolumab fiche patient | 1.69 | 0.1 | 9457 | 40 |
| ipilimumab and nivolumab patient information | 0.24 | 1 | 8806 | 8 |
| ipilimumab + nivolumab | 1.47 | 0.3 | 7243 | 63 |
| ipilimumab and nivolumab regimen | 0.46 | 0.3 | 1601 | 90 |
| nivolumab combined with ipilimumab | 1.71 | 0.7 | 2651 | 63 |
| combination of nivolumab and ipilimumab | 0.1 | 0.3 | 7842 | 7 |
| ipilimumab und nivolumab fachinfo | 1.06 | 0.4 | 4771 | 36 |
| ipilimumab and nivolumab protocol | 1.15 | 0.5 | 3824 | 82 |
| ipilimumab and nivolumab macmillan | 1.59 | 0.7 | 2298 | 26 |
| nivolumab ipilimumab lung cancer | 1.25 | 0.9 | 3469 | 5 |
| nivolumab and ipilimumab therapy | 0.41 | 0.3 | 7851 | 95 |
| nebenwirkungen ipilimumab und nivolumab | 0.99 | 0.9 | 7741 | 86 |
| ipilimumab and nivolumab drug class | 1.61 | 0.6 | 2029 | 3 |
